Cited by 66Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer’s Disease-like Pathology

Open access
Savas, Jeffrey N., Wang, Yi-Zhi, DeNardo, Laura A., Martinez-Bartolome, Salvador, McClatchy, Daniel B., Hark, Timothy J., Shanks, Natalie F., Cozzolino, Kira A. +9 more·2017·Cell Reports

Published version of a preprint

Abstract

Amyloid beta (Aβ) peptides impair multiple cellular pathways and play a causative role in Alzheimer's disease (AD) pathology, but how the brain proteome is remodeled by this process is unknown. To identify protein networks associated with AD-like pathology, we performed global quantitative proteomic analysis in three mouse models at young and old ages. Our analysis revealed a robust increase in Apolipoprotein E (ApoE) levels in nearly all brain regions with increased Aβ levels. Taken together with prior findings on ApoE driving Aβ accumulation, this analysis points to a pathological dysregulation of the ApoE-Aβ axis. We also found dysregulation of protein networks involved in excitatory synaptic transmission. Analysis of the AMPA receptor (AMPAR) complex revealed specific loss of TARPγ-2, a key AMPAR-trafficking protein. Expression of TARPγ-2 in hAPP transgenic mice restored AMPA currents. This proteomic database represents a resource for the identification of protein alterations responsible for AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2017.11.009

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The WAVE1 gene has been suggested as an AD-associated hub gene from studies of AD mouse models or human AD brains.

    “The WAVE1 gene has also been suggested as an AD-associated hub gene from studies of AD mouse models148 or human AD brains149.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. Akiyama H Barger S Barnum S Bradt B Bauer J Cole GM Cooper NR Eikelenboom P Emmerling M Fiebich BL 2000 Inflammation and Alzheimer’s disease Neurobiol Aging 21 383 421 10858586 PMC3887148
  2. Bartzokis G 2004 Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease Neurobiol Aging 25 5 18 author reply 49–62 14675724
  3. Bartzokis G Lu PH Mintz J 2007 Human brain myelination and amyloid beta deposition in Alzheimer’s disease Alzheimers Dement 3 122 125 18596894 PMC2442864
  4. Bertram L McQueen MB Mullin K Blacker D Tanzi RE 2007 Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat Genet 39 17 23 17192785
  5. Borchelt DR Thinakaran G Eckman CB Lee MK Davenport F Ratovitsky T Prada CM Kim G Seekins S Yager D 1996 Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1- 42/1–40 ratio in vitro and in vivo Neuron 17 1005 1013 8938131
  6. Braithwaite SP Xia H Malenka RC 2002 Differential roles for NSF and GRIP/ABP in AMPA receptor cycling Proc Natl Acad Sci U S A 99 7096 7101 12011465 PMC124534
  7. Ceglia I Reitz C Gresack J Ahn JH Bustos V Bleck M Zhang X Martin G Simon SM Nairn AC 2015 APP intracellular domain-WAVE1 pathway reduces amyloid-beta production Nat Med 21 1054 1059 26280122 PMC4560977
  8. Chang EH Savage MJ Flood DG Thomas JM Levy RB Mahadomrongkul V Shirao T Aoki C Huerta PT 2006 AMPA receptor downscaling at the onset of Alzheimer’s disease pathology in double knockin mice Proc Natl Acad Sci U S A 103 3410 3415 16492745 PMC1413872
  9. Chapman PF White GL Jones MW Cooper-Blacketer D Marshall VJ Irizarry M Younkin L Good MA Bliss TV Hyman BT 1999 Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice Nat Neurosci 2 271 276 10195221
  10. Dodart JC Meziane H Mathis C Bales KR Paul SM Ungerer A 1999 Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein Behav Neurosci 113 982 990 10571480
  11. Govek EE Newey SE Van Aelst L 2005 The role of the Rho GTPases in neuronal development Genes Dev 19 1 49 15630019
  12. Gupta VB Laws SM Villemagne VL Ames D Bush AI Ellis KA Lui JK Masters C Rowe CC Szoeke C 2011 Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging Neurology 76 1091 1098 21422459
  13. Hesse C Larsson H Fredman P Minthon L Andreasen N Davidsson P Blennow K 2000 Measurement of apolipoprotein E (apoE) in cerebrospinal fluid Neurochem Res 25 511 517 10823584
  14. Hirai K Aliev G Nunomura A Fujioka H Russell RL Atwood CS Johnson AB Kress Y Vinters HV Tabaton M 2001 Mitochondrial abnormalities in Alzheimer’s disease J Neurosci 21 3017 3023 11312286 PMC6762571
  15. Holtzman DM Herz J Bu G 2012 Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease Cold Spring Harb Perspect Med 2 a006312 22393530 PMC3282491
  16. Hsieh H Boehm J Sato C Iwatsubo T Tomita T Sisodia S Malinow R 2006 AMPAR removal underlies A beta-induced synaptic depression and dendritic spine loss Neuron 52 831 843 17145504 PMC1850952
  17. Kanehisa M Goto S 2000 KEGG: kyoto encyclopedia of genes and genomes Nucleic Acids Res 28 27 30 10592173 PMC102409
  18. Kim Y Sung JY Ceglia I Lee KW Ahn JH Halford JM Kim AM Kwak SP Park JB Ho Ryu S 2006 Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology Nature 442 814 817 16862120
  19. Kristensen AS Jenkins MA Banke TG Schousboe A Makino Y Johnson RC Huganir R Traynelis SF 2011 Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating Nat Neurosci 14 727 735 21516102 PMC3102786
  20. Kuo YM Crawford F Mullan M Kokjohn TA Emmerling MR Weller RO Roher AE 2000 Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer’s disease Mol Med 6 430 439 10952022 PMC1949958
  21. Lalonde R Kim HD Maxwell JA Fukuchi K 2005 Exploratory activity and spatial learning in 12- month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques Neurosci Lett 390 87 92 16169151
  22. Langfelder P Horvath S 2007 Eigengene networks for studying the relationships between co-expression modules BMC Syst Biol 1 54 18031580 PMC2267703
  23. Langfelder P Horvath S 2008 WGCNA: an R package for weighted correlation network analysis BMC Bioinformatics 9 559 19114008 PMC2631488
  24. Lassmann H Weiler R Fischer P Bancher C Jellinger K Floor E Danielczyk W Seitelberger F Winkler H 1992 Synaptic pathology in Alzheimer’s disease: immunological data for markers of synaptic and large dense-core vesicles Neuroscience 46 1 8 1594095
  25. Lin MT Beal MF 2006 Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 787 795 17051205
  26. Liu CC Kanekiyo T Xu H Bu G 2013 Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Nat Rev Neurol 9 106 118 23296339 PMC3726719
  27. Liu Q Zerbinatti CV Zhang J Hoe HS Wang B Cole SL Herz J Muglia L Bu G 2007 Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1 Neuron 56 66 78 17920016 PMC2045076
  28. MacCoss MJ Wu CC Matthews DE Yates JR 3rd 2005 Measurement of the isotope enrichment of stable isotope-labeled proteins using high-resolution mass spectra of peptides Anal Chem 77 7646 7653 16316172
  29. McClatchy DB Dong MQ Wu CC Venable JD Yates JR 3rd 2007 15N metabolic labeling of mammalian tissue with slow protein turnover J Proteome Res 6 2005 2010 17375949 PMC2527585
  30. McGowan E Pickford F Kim J Onstead L Eriksen J Yu C Skipper L Murphy MP Beard J Das P 2005 Abeta42 is essential for parenchymal and vascular amyloid deposition in mice Neuron 47 191 199 16039562 PMC1373682
  31. Milstein AD Zhou W Karimzadegan S Bredt DS Nicoll RA 2007 TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating Neuron 55 905 918 17880894 PMC3167227
  32. Mori H Kondo J Ihara Y 1987 Ubiquitin is a component of paired helical filaments in Alzheimer’s disease Science 235 1641 1644 3029875
  33. Mucke L Masliah E Yu GQ Mallory M Rockenstein EM Tatsuno G Hu K Kholodenko D Johnson-Wood K McConlogue L 2000 High-level neuronal expression of abeta 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J Neurosci 20 4050 4058 10818140 PMC6772621
  34. Nakagawa T Cheng Y Ramm E Sheng M Walz T 2005 Structure and different conformational states of native AMPA receptor complexes Nature 433 545 549 15690046
  35. Namba Y Tomonaga M Kawasaki H Otomo E Ikeda K 1991 Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease Brain Res 541 163 166 2029618
  36. Park SK Venable JD Xu T Yates JR 3rd 2008 A quantitative analysis software tool for mass spectrometry-based proteomics Nat Methods 5 319 322 18345006 PMC3509211
  37. Powers ET Morimoto RI Dillin A Kelly JW Balch WE 2009 Biological and chemical approaches to diseases of proteostasis deficiency Annu Rev Biochem 78 959 991 19298183
  38. Reinders NR Pao Y Renner MC da Silva-Matos CM Lodder TR Malinow R Kessels HW 2016 Amyloid-beta effects on synapses and memory require AMPA receptor subunit GluA3 Proc Natl Acad Sci U S A 113 E6526 E6534 27708157 PMC5081598
  39. Savas JN Ribeiro LF Wierda KD Wright R DeNardo-Wilke LA Rice HC Chamma I Wang YZ Zemla R Lavallee-Adam M 2015 The Sorting Receptor SorCS1 Regulates Trafficking of Neurexin and AMPA Receptors Neuron 87 764 780 26291160 PMC4692362
  40. Schnell E Sizemore M Karimzadegan S Chen L Bredt DS Nicoll RA 2002 Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number Proc Natl Acad Sci U S A 99 13902 13907 12359873 PMC129795
  41. Schwenk J Harmel N Brechet A Zolles G Berkefeld H Muller CS Bildl W Baehrens D Huber B Kulik A 2012 High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes Neuron 74 621 633 22632720
  42. Seyfried NT Dammer EB Swarup V Nandakumar D Duong DM Yin L Deng Q Nguyen T Hales CM Wingo T 2017 A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease Cell Syst 4 60 72 e64 27989508 PMC5269514
  43. Shankar GM Li S Mehta TH Garcia-Munoz A Shepardson NE Smith I Brett FM Farrell MA Rowan MJ Lemere CA 2008 Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory Nat Med 14 837 842 18568035 PMC2772133
  44. Shanks NF Savas JN Maruo T Cais O Hirao A Oe S Ghosh A Noda Y Greger IH Yates JR 3rd 2012 Differences in AMPA and kainate receptor interactomes facilitate identification of AMPA receptor auxiliary subunit GSG1L Cell Rep 1 590 598 22813734 PMC3401968
  45. Terry RD Masliah E Salmon DP Butters N DeTeresa R Hill R Hansen LA Katzman R 1991 Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 572 580 1789684
  46. Wang J Tanila H Puolivali J Kadish I van Groen T 2003 Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice Neurobiol Dis 14 318 327 14678749
  47. Wu CC MacCoss MJ Howell KE Matthews DE Yates JR 3rd 2004 Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis Anal Chem 76 4951 4959 15373428
  48. Yamaguchi H Yamazaki T Ishiguro K Shoji M Nakazato Y Hirai S 1992 Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes Acta Neuropathol 85 15 22 1363016
  49. Yamamoto A Suzuki T Sakaki Y 2001 Isolation of hNap1BP which interacts with human Nap1 (NCKAP1) whose expression is down-regulated in Alzheimer’s disease Gene 271 159 169 11418237
  50. Yamasaki M Fukaya M Yamazaki M Azechi H Natsume R Abe M Sakimura K Watanabe M 2016 TARP gamma-2 and gamma-8 Differentially Control AMPAR Density Across Schaffer Collateral/Commissural Synapses in the Hippocampal CA1 Area J Neurosci 36 4296 4312 27076426 PMC6601775
  51. Zhang B Gaiteri C Bodea LG Wang Z McElwee J Podtelezhnikov AA Zhang C Xie T Tran L Dobrin R 2013 Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease Cell 153 707 720 23622250 PMC3677161
  52. Zhang B Horvath S 2005 A general framework for weighted gene co-expression network analysis Stat Appl Genet Mol Biol 4 Article17 16646834

Cited by

Sorted by citations

Authors
Savas, J. N., Wang, Y.-Z., DeNardo, L. A., Martinez-Bartolome, S., McClatchy, D. B., Hark, T. J., Shanks, N. F., Cozzolino, K. A., Lavallée-Adam, M., Smukowski, S. N., Park, S. K., Kelly, J. W., Koo, E. H., Nakagawa, T., Masliah, E., Ghosh, A., & Yates, J. R.
Affiliations
  • Northwestern University (US)
  • University of California San Diego (US)
  • Scripps Research Institute (US)
Corresponding author
  • Savas, Jeffrey N.
  • Yates, John R.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2017-11
Volume
21
Issue
9
Pages
2614-2627
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2625912305
Cited by
66
References
13
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 10 · 2020: 13 · 2019: 11 · 2018: 5
FWCI
5.64
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NIH (F32AG039127, R00DC013805, R01MH067880, P41GM103533, P30CA060553)
  • Fonds de Recherche du Québec—Nature et Technologies fellowship
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Alzheimer's disease, amyloid-beta, apolipoprotein E, brain proteome, AMPA receptors, excitatory synaptic transmission, protein networks
MeSH terms
Alzheimer Disease, Animals, Apolipoproteins E, Brain, Female, Mice, Inbred C57BL, Mass Spectrometry, Calcium Channels, Amyloid beta-Peptides, Computational Biology, Proteome, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review